ODAC 30% Off Registration, Use Code: JDD30
Skip to main content

A Moisturizer With Centella asiatica and Mandelic Acid Reduces Bruising and Speeds Recovery in Mature Skin

November 2026 | Volume 25 | Issue 11 | 1059 | Copyright © November 2026


Published online October 30, 2026

Todd Schlesinger MDa,b, Glynis Ablon MD FAADc,d, Alan Widgerow MBBCh MMed FCS FACSe, Christine Emesiani PharmDe, Sindhu Garimella MSe, Thu Q. Nguyen PhDe, JP York PhDe, Matthew Meckfessel PhDe

aClinical Research Center of the Carolinas, Charleston, SC
bDepartment of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC
cDepartment of Dermatology, University of California, Los Angeles, Los Angeles, CA
dAblon Skin Institute & Research Center, Manhattan Beach, CA
eGalderma Laboratories, L.P., Fort Worth, TX

Abstract
Background: Dermatoporosis is a chronic cutaneous insufficiency syndrome characterized by skin atrophy, purpura, bruising, delayed healing, and increased injury susceptibility. This study evaluated an investigational cream, GC (Galderma Laboratories, L.P., Fort Worth, TX), in subjects with mature, crepey, bruise-prone skin, using a novel method to assess bruise severity and duration.
Methods: This 12-week multicenter, randomized, blinded, in-use study recruited men and women aged 40 to 60 years with fragile, bruise-prone skin to apply GC cream twice daily to knees and thighs. A subset of 15 subjects underwent electric cupping on
1 randomized upper knee at baseline and week 12 to induce localized ecchymosis. Bruise severity was evaluated 15 minutes postinduction by investigators using standardized photography, and subjects captured daily images until resolution. Safety, tolerability, and subject satisfaction were assessed throughout.
Results: After 12 weeks of GC cream use, investigator-assessed bruise severity score was significantly lower than baseline (mean [SD] 3.27 [1.33] vs 4.13 [1.02]; [P=.0087]). Days to bruise resolution were also numerically shorter at week 12 compared with baseline (mean [SE] 6.33 [0.91] vs 8.00 [0.56]; [log-rank P=.3134]). Serial photography confirmed expected temporal evolution and resolution of bruising and supported improvement in investigator-assessed severity. Subject satisfaction was high, and there were no related adverse events.
Conclusion: Twelve weeks of twice-daily GC cream use significantly reduced bruise severity induced by electric cupping and helped bruises resolve faster. These findings support GC cream as an important new option to reduce bruise potential and improve skin health of subjects with dermatoporosis.

 

INTRODUCTION

Dermatoporosis is a cutaneous syndrome characterized by a progressive loss of skin strength and structural integrity.1-4 Its clinical features include atrophy, purpura, lacerations, delayed healing, and, in advanced cases, dissecting hematomas.1-4 Skin fragility may range from thinning, wrinkling, and laxity in midlife to marked atrophy with purpuric lesions in older individuals.2,5,6 This spectrum reflects the varying contributions of intrinsic aging, photoaging, environmental exposure, and other factors that drive tissue decline.5,6

Visible bruising is a clinically relevant feature of dermatoporosis because it is readily apparent to subjects, can be distressing, and may indicate reduced tissue support.7,8 In mature skin, dermal thinning, extracellular matrix deterioration, vascular fragility, and reduced subcutaneous support can lower the threshold for vessel rupture and ecchymosis.7,8 Morphologic studies using reflectance confocal microscopy and ultrasonography have demonstrated structural changes in dermatoporosis, supporting the value of objective assessment of skin structure in this condition.9

The biology of bruise-prone mature skin is multifactorial. Intrinsic aging and chronic ultraviolet exposure alter epidermal function, collagen and elastin organization, dermal thickness, vascular support, and skin biomechanics.10-13 Type I collagen loss contributes to dermal thinning and reduced tensile strength, while altered hyaluronan-CD44 signaling has been implicated in dermatoporosis-associated atrophy and purpura.14-17 Cellular senescence provides another mechanistic framework for age-related skin fragility, as senescent fibroblasts and keratinocytes